161 related articles for article (PubMed ID: 371860)
21. An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea.
Glass MR; Shaw RW; Butt WR; Edwards RL; London DR
Br Med J; 1975 Aug; 3(5978):274-5. PubMed ID: 1170923
[TBL] [Abstract][Full Text] [Related]
22. Pituitary function in young women in a reformatory institution.
Adamopoulos DA; Ierapetritakis G; Kapolla N
Br J Obstet Gynaecol; 1982 Jul; 89(7):511-5. PubMed ID: 6807338
[TBL] [Abstract][Full Text] [Related]
23. [Prolactin adenoma. Study of gonadotrophic function by the sassoles G LHRH test].
Tourniaire J; Pallo D; Fèvre M; Ponsin G; Mazenod B; Bachelot I; Sassolas G
Nouv Presse Med; 1975 Apr; 4(17):1263-6. PubMed ID: 1098013
[TBL] [Abstract][Full Text] [Related]
24. On the correlation of luteinizing hormone-releasing hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin levels in plasma of women with normal menstrual cycles.
Aksel S
Am J Obstet Gynecol; 1981 Oct; 141(4):362-7. PubMed ID: 6792924
[TBL] [Abstract][Full Text] [Related]
25. Galactorrhea in sarcoidosis: dynamic studies of prolactin, growth and gonadotropic hormone levels.
Caro JF; Israel HL; Glennon JA
Am J Med Sci; 1979; 277(3):289-94. PubMed ID: 110148
[TBL] [Abstract][Full Text] [Related]
26. Functional evaluation of pituitary reserve in patients with the amenorrhea-galactorrhea syndrome utilizing luteinizing hormone-releasing hormone (LH-RH), L-dopa and chlorpromazine.
Zárate A; Jacobs LS; Canales ES; Schally AV; De la Cruz A; Soria J; Daughaday WH
J Clin Endocrinol Metab; 1973 Dec; 37(6):855-9. PubMed ID: 4584924
[No Abstract] [Full Text] [Related]
27. Factors influencing the dynamics of gonadotropin response following bolus infusion of luteinizing hormone-releasing factor in women with menstrual abnormalities.
Cantor B; Kalra PS; Buhi WC; Birk SA; Spellacy WN
Fertil Steril; 1977 May; 28(5):526-30. PubMed ID: 323072
[TBL] [Abstract][Full Text] [Related]
28. Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women.
Jeppsson S; Rannevik G; Thorell JI; Wide L
Acta Endocrinol (Copenh); 1977 Apr; 84(4):713-28. PubMed ID: 322431
[TBL] [Abstract][Full Text] [Related]
29. Effect of sulpiride on plasma prolactin levels in women with puerperal or pathological hyperprolactinaemia.
Massara F; Camanni F; Belforte L; Campagnoli C; Novi RF; Molinatti GM
Acta Endocrinol (Copenh); 1980 Oct; 95(2):145-50. PubMed ID: 7435113
[TBL] [Abstract][Full Text] [Related]
30. Functional and post-oral contraceptive amenorrhoea: response to luteinizing hormone releasing hormone (LH-RH).
Jequier AM; O'Shea A; Jacobs HS
Br J Obstet Gynaecol; 1975 Apr; 82(4):333-6. PubMed ID: 1092321
[TBL] [Abstract][Full Text] [Related]
31. Amenorrhea following oral contraception.
Smiljanić N; Ciglar S; Bistricki J
Acta Obstet Gynecol Scand; 1980; 59(3):261-4. PubMed ID: 6775490
[TBL] [Abstract][Full Text] [Related]
32. Therapy-orientated diagnosis of secondary amenorrhoea.
Jacobs HS; Hull MG; Murray MA; Franks S
Horm Res; 1975; 6(4):268-87. PubMed ID: 773806
[TBL] [Abstract][Full Text] [Related]
33. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
[TBL] [Abstract][Full Text] [Related]
34. Effect of active and passive immunization with luteinizing hormone-releasing hormone on serum luteinizing hormone and follicle-stimulating hormone levels and the ultrastructure of the pituitary gonadotrophs in castrated male rats.
Arimura A; Shino M; de la Cruz KG; Rennels EG; Schally AV
Endocrinology; 1976 Jul; 99(1):291-303. PubMed ID: 780100
[TBL] [Abstract][Full Text] [Related]
35. Modern management of secondary amenorrhoea.
Banerjee S
Calcutta Med J; 1989; 86(5-6):46-9. PubMed ID: 12284231
[TBL] [Abstract][Full Text] [Related]
36. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
[TBL] [Abstract][Full Text] [Related]
37. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
38. Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes.
Del Pozo E; Varga L; Wyss H; Tolis G; Friesen H; Wenner R; Vetter L; Uettwiler A
J Clin Endocrinol Metab; 1974 Jul; 39(1):18-26. PubMed ID: 4209685
[No Abstract] [Full Text] [Related]
39. Effect of epimestrol on gonadotropin and prolactin plasma levels and response to luteinizing hormone-releasing hormone/thyrotropin-releasing hormone in secondary amenorrhea and oligomenorrhea.
Genazzani AR; Facchinetti F; de Leo V; Picciolini E; Franchi F; Parrini D; Kicovic PM
Fertil Steril; 1978 Dec; 30(6):654-60. PubMed ID: 153243
[TBL] [Abstract][Full Text] [Related]
40. [Sulpiride amenorrhea-galactorrhea syndrome. Clinical contribution].
Ravizza L
Minerva Psichiatr; 1980; 21(3):205-13. PubMed ID: 7193270
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
